Our Mission
We believe that plant extractions create new opportunities for medical formulations.
Talent, driven by the awareness of creating perfect pharmaceutical compositions, is the result of our intensive work.
Dr. Boguslaw W. Jelen
CEO of Bio-Yellen , LLC
Dr. Boguslaw Wojciech Jelen, CEO of Bio-Yellen, LLC
and the developer of pharmaceutical compositions with antiviral and immunological properties.
Dr. Jelen graduated from medical school in Poland. After his residency, he moved to Switzerland and started research on Human Immunodeficiency Viruses. His research led to several patents in which Dr. Jelen presented a pharmaceutical mixture and a method of producing a therapeutic composition for blocking HIV-1 and HIV-2 virus replication in CD4+ cells of the human immune system at all stages of viral infection.
He continued his research on viruses in the United States, working with the parent company Excyton-Excymer. The news about SarS-Cov2 prompted Dr. Jelen to begin carefully analyzing the aggressiveness of this virus, looking back to the scientific literature from the early 2000s. As a result of his work, Dr. Jelen developed a pharmaceutical formulation that could become protective against virus replication. The antiviral efficacy of the new formula was confirmed at the Institute of Virology in Basel. Currently, Dr. Jelen continues to research pharmaceutical solutions to fight viral and bacterial infections, utilizing the power of medicinal ingredients found in nature.
